Details for Patent: 12,171,882
Which drugs does patent 12,171,882 protect, and when does it expire?
Patent 12,171,882 protects TARPEYO and is included in one NDA.
This patent has twenty-six patent family members in fourteen countries.
Summary for Patent: 12,171,882
| Title: | Pharmaceutical compositions |
| Abstract: | The present invention provides for a method of treatment of IgA nephropathy, which method comprises: |
| Inventor(s): | Eva Kristina RIESEL, Lena Margareta PERESWETOFF-MORATH, Kari SANDVOLD, Christian Olle Andreas PEDERSEN |
| Assignee: | Calliditas Therapeutics AB |
| Application Number: | US18/392,602 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,171,882 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 12,171,882
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calliditas | TARPEYO | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 215935-001 | Dec 15, 2021 | RX | Yes | Yes | 12,171,882 | ⤷ Start Trial | REDUCTION IN LOSS OF KIDNEY FUNCTION IN ADULTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN) WHO ARE AT RISK OF DISEASE PROGRESSION, BY RELEASE OF BUDESONIDE FROM THE FORMULATION | ⤷ Start Trial | ||||
| Calliditas | TARPEYO | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 215935-001 | Dec 15, 2021 | RX | Yes | Yes | 12,171,882 | ⤷ Start Trial | REDUCTION OF PROTEINURIA IN ADULTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN) WHO ARE AT RISK OF DISEASE PROGRESSION, BY RELEASE OF BUDESONIDE FROM THE FORMULATION | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,171,882
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2023210461 | ⤷ Start Trial | |||
| Canada | 3249575 | ⤷ Start Trial | |||
| Chile | 2024002201 | ⤷ Start Trial | |||
| China | 118591376 | ⤷ Start Trial | |||
| China | 120053463 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
